These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8172810)
21. The multichain interleukin-2 receptor: a target for immunotherapy. Waldmann TA; Pastan IH; Gansow OA; Junghans RP Ann Intern Med; 1992 Jan; 116(2):148-60. PubMed ID: 1727619 [TBL] [Abstract][Full Text] [Related]
22. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells. Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072 [TBL] [Abstract][Full Text] [Related]
23. The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts. Waldmann TA; Goldman CK Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):45-53. PubMed ID: 2683757 [TBL] [Abstract][Full Text] [Related]
24. The interleukin-2 receptor on malignant cells: a target for diagnosis and therapy. Waldmann TA Cell Immunol; 1986 Apr; 99(1):53-60. PubMed ID: 3019574 [TBL] [Abstract][Full Text] [Related]
25. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia. Uchiyama T; Wano Y; Tsudo M; Umadome H; Hori T; Tamori S; Uchino H; Yodoi J; Maeda M; Kobayashi N Princess Takamatsu Symp; 1984; 15():253-8. PubMed ID: 6100643 [TBL] [Abstract][Full Text] [Related]
27. Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia. Waldmann TA; Longo DL; Leonard WJ; Depper JM; Thompson CB; Krönke M; Goldman CK; Sharrow S; Bongiovanni K; Greene WC Cancer Res; 1985 Sep; 45(9 Suppl):4559s-4562s. PubMed ID: 2990687 [TBL] [Abstract][Full Text] [Related]
28. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac. Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783 [TBL] [Abstract][Full Text] [Related]
29. Biology and treatment of HTLV-1 associated T-cell lymphomas. Tsukasaki K; Tobinai K Best Pract Res Clin Haematol; 2013 Mar; 26(1):3-14. PubMed ID: 23768636 [TBL] [Abstract][Full Text] [Related]
30. Lymphokine receptor-directed therapy: a model for immune intervention in leukemia, autoimmunity, and immunodeficiency. Waldmann TA Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S37-46. PubMed ID: 1934612 [TBL] [Abstract][Full Text] [Related]
31. Comparison of anti-Tac and anti-transferrin receptor-conjugated liposomes for specific drug delivery to adult T-cell leukemia. Hege KM; Daleke DL; Waldmann TA; Matthay KK Blood; 1989 Nov; 74(6):2043-52. PubMed ID: 2679914 [TBL] [Abstract][Full Text] [Related]
32. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Tendler CL; Greenberg SJ; Blattner WA; Manns A; Murphy E; Fleisher T; Hanchard B; Morgan O; Burton JD; Nelson DL Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5218-22. PubMed ID: 2367534 [TBL] [Abstract][Full Text] [Related]
33. Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma. Waldmann TA Oncogene; 2007 May; 26(25):3699-703. PubMed ID: 17530023 [TBL] [Abstract][Full Text] [Related]
34. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation. Waldmann TA; Tsudo M Prog Clin Biol Res; 1988; 262():283-93. PubMed ID: 2897696 [TBL] [Abstract][Full Text] [Related]
35. Recent advances in the treatment of adult T-cell leukemia-lymphomas. Utsunomiya A; Choi I; Chihara D; Seto M Cancer Sci; 2015 Apr; 106(4):344-51. PubMed ID: 25613789 [TBL] [Abstract][Full Text] [Related]
36. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation. Waldmann TA Environ Health Perspect; 1987 Nov; 75():11-5. PubMed ID: 2891501 [TBL] [Abstract][Full Text] [Related]
37. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL]. Tanaka Y; Kanda Y Rinsho Ketsueki; 2015 Jul; 56(7):815-24. PubMed ID: 26251144 [TBL] [Abstract][Full Text] [Related]
38. Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia. Kreitman RJ; Chaudhary VK; Waldmann TA; Hanchard B; Cranston B; FitzGerald DJ; Pastan I Leukemia; 1993 Apr; 7(4):553-62. PubMed ID: 8464234 [TBL] [Abstract][Full Text] [Related]
39. Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy. Kozak RW; Atcher RW; Gansow OA; Friedman AM; Hines JJ; Waldmann TA Proc Natl Acad Sci U S A; 1986 Jan; 83(2):474-8. PubMed ID: 3079913 [TBL] [Abstract][Full Text] [Related]
40. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia. Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]